|
10BagR, part 2 - repost attempt number don't know what
|
1
|
Resverlogix Corp.
|
Nov 27, 2020 04:21PM
|
|
10BagR, part 1 - repost attempt number don't know what
|
2
|
Resverlogix Corp.
|
Nov 27, 2020 04:18PM
|
|
No idea what causes it to bounce
|
3
|
Resverlogix Corp.
|
Nov 27, 2020 04:11PM
|
|
Re: From abstract 6 days ago: BRD inhibitors are promising candidates to prevent COVID-19 mediated cardiac damage
|
5
|
Resverlogix Corp.
|
Oct 21, 2020 02:28PM
|
|
From abstract 6 days ago: BRD inhibitors are promising candidates to prevent COVID-19 mediated cardiac damage
|
6
|
Resverlogix Corp.
|
Oct 21, 2020 01:59PM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
10
|
Resverlogix Corp.
|
Oct 14, 2020 03:00PM
|
|
Re: Leading From Behind
|
10
|
Resverlogix Corp.
|
Oct 13, 2020 04:41PM
|
|
If anyone still cares about science...
|
9
|
Resverlogix Corp.
|
Oct 09, 2020 04:38PM
|
|
Re: RVX rises above 200-day moving average
|
6
|
Resverlogix Corp.
|
Sep 21, 2020 03:26PM
|
|
Re: Bear
|
5
|
Resverlogix Corp.
|
Jul 19, 2020 11:28AM
|
|
REPROGRAM - trial with RVX208.
|
5
|
Resverlogix Corp.
|
Jul 13, 2020 04:23PM
|
|
Re: Constellation Pharma
|
12
|
Resverlogix Corp.
|
Jun 30, 2020 08:29AM
|
|
Re: Entresto Trial (Novartis)
|
4
|
Resverlogix Corp.
|
Jun 24, 2020 02:47AM
|
|
Re: Still waiting for that BETonMACE CKD sub-study 7 months later
|
3
|
Resverlogix Corp.
|
Jun 13, 2020 04:43PM
|
|
IP considerations may prevent RVX from disclosing eGFR data
|
9
|
Resverlogix Corp.
|
Jun 08, 2020 03:35PM
|
|
Re: Lower LDL-C and Increased Type 2 Diabetes Risk - Bear
|
9
|
Resverlogix Corp.
|
Jun 06, 2020 02:14PM
|
|
Apabetalone, a drug that reduces MACE in CKD patients
|
18
|
Resverlogix Corp.
|
Jun 05, 2020 05:03PM
|
|
Re: Nature Article on the role of Endothelial Cells in COVID 19 - new article
|
4
|
Resverlogix Corp.
|
Jun 03, 2020 01:58PM
|
|
Re: Is this relevant to RVX
|
5
|
Resverlogix Corp.
|
May 17, 2020 11:21AM
|
|
Resverlogix is hopefully applying for governmental fund for MACE in Covid-19
|
16
|
Resverlogix Corp.
|
May 10, 2020 04:16PM
|
